261763-23-9

Usage

Uses

Used in Pharmaceutical Industry:
4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE is employed as an intermediate in the production of agrochemicals, aiding in the creation of compounds that protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE is utilized as a reagent in organic synthesis, specifically for introducing the benzyl bromide functionality into a range of compounds, which is crucial for the formation of new organic molecules with desired properties.
Used in Specialty Chemicals Production:
4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE also serves as a building block in the production of specialty chemicals, where its unique structure and reactivity enable the creation of high-value chemical products for various applications.

InChI:InChI=1/C8H5BrClF3/c9-4-5-1-2-7(10)6(3-5)8(11,12)13/h1-3H,4H2

Upstream product

• 65735-71-9 (4-chloro-3-(trifluoromethyl)phenyl)methanol 

Downstream Products

• 22902-82-5 2-(4-chloro-3-(trifluoromethyl)phenyl)acetonitrile 
• 1381792-60-4 4-(4-chloro-3-(trifluoromethyl)benzyl)benzaldehyde 
• 950995-12-7 2-[4-chloro-3-(trifluoromethyl)phenyl]propanoic acid 
• 1418144-66-7 (E)-1-(3-ethyl-4-(hydroxymethyl)phenyl)ethan-1-one-O-(4-cyclohexyl-3-(trifluoromethyl)benzyl)-oxime 
• 1418144-65-6 N-(4-cyclohexyl-3-trifluoromethylbenzyloxy)acetimidic acid ethyl ester 
• 1230487-00-9 Siponimod 
• 1418144-64-5 N-(4-chloro-3-trifluoromethylbenzyloxy)acetimidic acid ethyl ester 
• 1335027-69-4 ethyl 2-(4-chloro-3-(trifluoromethyl)benzyl)-3-(3-methoxycyclobutyl)-3-oxopropanoate 
• 1335027-55-8 ethyl 2-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-3-cyclobutyl-3-oxo-propanoate 
• 1215118-83-4 tert-butyl 2-(7-(4-chloro-3-(trifluoromethyl)benzyloxy)-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate 
• 1314864-65-7 C₁₂H₈ClF₃N₂O₂ 
• 1314864-66-8 C₁₁H₇ClF₃N₃O₂ 
• 1295542-07-2 C₁₅H₁₂ClF₃N₆O 
• 1295542-04-9 C₁₆H₁₃ClF₃N₅O 

Relevant academic research and scientific papers

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2 H-benzo[ b][1,4]oxazin-6-yl Moiety

The therapeutic potential of monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases has attracted attention worldwide. However, the availability of reversible-type inhibitor is still limited to clarify the pharmacological eff

TISSUE FACTOR PRODUCTION INHIBITOR

A medicament which has an activity of inhibiting production of tissue factor and comprises an LXR ligand as an active ingredient; and a medicament for treatment and/or prophylaxis of vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, or treatment and/or prophylaxis of blood coagulation diseases, diseases induced by platelet aggregation including stable or unstable angina pectoris, cardiovascular and cerebrovascular diseases including thromboembolism formation diseases accompanying diabetes, rethrombosis following thrombolysis, cerebral ischemic attack, infarction, stroke, ischemia-derived dementia, peripheral artery disease, thromboembolism formation diseases during use of an aorta-coronary artery bypass, glomerulosclerosis, renal embolism, tumor or cancer metastasis, which comprises an LXR ligand as an active ingredient.